Cargando…
Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes
INTRODUCTION: Preventing the development and progression of diabetic microvascular complications through optimal blood glucose control remains an important challenge. Whether metrics based on continuous glucose monitoring are useful for the management of diabetic microvascular complications is not e...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061826/ https://www.ncbi.nlm.nih.gov/pubmed/33879513 http://dx.doi.org/10.1136/bmjdrc-2020-001923 |
_version_ | 1783681641163522048 |
---|---|
author | Wakasugi, Satomi Mita, Tomoya Katakami, Naoto Okada, Yosuke Yoshii, Hidenori Osonoi, Takeshi Nishida, Keiko Shiraiwa, Toshihiko Torimoto, Keiichi Kurozumi, Akira Gosho, Masahiko Shimomura, Iichiro Watada, Hirotaka |
author_facet | Wakasugi, Satomi Mita, Tomoya Katakami, Naoto Okada, Yosuke Yoshii, Hidenori Osonoi, Takeshi Nishida, Keiko Shiraiwa, Toshihiko Torimoto, Keiichi Kurozumi, Akira Gosho, Masahiko Shimomura, Iichiro Watada, Hirotaka |
author_sort | Wakasugi, Satomi |
collection | PubMed |
description | INTRODUCTION: Preventing the development and progression of diabetic microvascular complications through optimal blood glucose control remains an important challenge. Whether metrics based on continuous glucose monitoring are useful for the management of diabetic microvascular complications is not entirely clear. RESEARCH DESIGN AND METHODS: This is an exploratory analysis of an ongoing prospective, multicenter, 5-year follow-up observational study. Study participants included 999 outpatients with type 2 diabetes who underwent continuous glucose monitoring at baseline. Associations between continuous glucose monitoring-derived metrics and the severity of diabetic retinopathy or albuminuria were investigated using multivariable proportional odds models. RESULTS: The overall prevalence of diabetic retinopathy was 22.2%. Multivariate analysis with proportional odds models demonstrated that continuous glucose monitoring-derived metrics related to intraday and interday glucose variability are significantly associated with the severity of diabetic retinopathy, even after adjusting for various possible risk factors. However, significant relationships were not observed after adjusting for hemoglobin A1c (HbA1c) levels. The prevalence of microalbuminuria and macroalbuminuria was 20.3% and 6.7%, respectively. Similarly, multivariate analysis demonstrated that those metrics are significantly associated with the severity of albuminuria. These relationships remained significant even after further adjusting for HbA1c levels. CONCLUSIONS: Continuous glucose monitoring-derived metrics related to intraday and interday glucose variability are significantly associated with the severity of diabetic retinopathy or albuminuria in patients with type 2 diabetes. Thus, evaluating these metrics might possibly be useful for risk assessment of diabetic microvascular complications. Trial registration number UMIN000032325. |
format | Online Article Text |
id | pubmed-8061826 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-80618262021-05-11 Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes Wakasugi, Satomi Mita, Tomoya Katakami, Naoto Okada, Yosuke Yoshii, Hidenori Osonoi, Takeshi Nishida, Keiko Shiraiwa, Toshihiko Torimoto, Keiichi Kurozumi, Akira Gosho, Masahiko Shimomura, Iichiro Watada, Hirotaka BMJ Open Diabetes Res Care Pathophysiology/Complications INTRODUCTION: Preventing the development and progression of diabetic microvascular complications through optimal blood glucose control remains an important challenge. Whether metrics based on continuous glucose monitoring are useful for the management of diabetic microvascular complications is not entirely clear. RESEARCH DESIGN AND METHODS: This is an exploratory analysis of an ongoing prospective, multicenter, 5-year follow-up observational study. Study participants included 999 outpatients with type 2 diabetes who underwent continuous glucose monitoring at baseline. Associations between continuous glucose monitoring-derived metrics and the severity of diabetic retinopathy or albuminuria were investigated using multivariable proportional odds models. RESULTS: The overall prevalence of diabetic retinopathy was 22.2%. Multivariate analysis with proportional odds models demonstrated that continuous glucose monitoring-derived metrics related to intraday and interday glucose variability are significantly associated with the severity of diabetic retinopathy, even after adjusting for various possible risk factors. However, significant relationships were not observed after adjusting for hemoglobin A1c (HbA1c) levels. The prevalence of microalbuminuria and macroalbuminuria was 20.3% and 6.7%, respectively. Similarly, multivariate analysis demonstrated that those metrics are significantly associated with the severity of albuminuria. These relationships remained significant even after further adjusting for HbA1c levels. CONCLUSIONS: Continuous glucose monitoring-derived metrics related to intraday and interday glucose variability are significantly associated with the severity of diabetic retinopathy or albuminuria in patients with type 2 diabetes. Thus, evaluating these metrics might possibly be useful for risk assessment of diabetic microvascular complications. Trial registration number UMIN000032325. BMJ Publishing Group 2021-04-20 /pmc/articles/PMC8061826/ /pubmed/33879513 http://dx.doi.org/10.1136/bmjdrc-2020-001923 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Pathophysiology/Complications Wakasugi, Satomi Mita, Tomoya Katakami, Naoto Okada, Yosuke Yoshii, Hidenori Osonoi, Takeshi Nishida, Keiko Shiraiwa, Toshihiko Torimoto, Keiichi Kurozumi, Akira Gosho, Masahiko Shimomura, Iichiro Watada, Hirotaka Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes |
title | Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes |
title_full | Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes |
title_fullStr | Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes |
title_full_unstemmed | Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes |
title_short | Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes |
title_sort | associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes |
topic | Pathophysiology/Complications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061826/ https://www.ncbi.nlm.nih.gov/pubmed/33879513 http://dx.doi.org/10.1136/bmjdrc-2020-001923 |
work_keys_str_mv | AT wakasugisatomi associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes AT mitatomoya associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes AT katakaminaoto associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes AT okadayosuke associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes AT yoshiihidenori associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes AT osonoitakeshi associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes AT nishidakeiko associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes AT shiraiwatoshihiko associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes AT torimotokeiichi associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes AT kurozumiakira associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes AT goshomasahiko associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes AT shimomuraiichiro associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes AT watadahirotaka associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes |